53
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      scite_
      0
      0
      0
      0
      Smart Citations
      0
      0
      0
      0
      Citing PublicationsSupportingMentioningContrasting
      View Citations

      See how this article has been cited at scite.ai

      scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.

       
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Neurofibroma revealed as malignant peripheral nerve sheath tumor: a case report

      Published
      case-report
      Bookmark

            Abstract

            Background:

            Peripheral nerve sheath tumors (PNST) can be categorized into benign or malignant on the basis of imaging findings on ultrasonography (USG) and magnetic resonance imaging (MRI).

            Case Presentation:

            We report a case of a 28-year-old male presented with a huge swelling in his right forearm. While the features of MRI suggested neurofibroma, some of the features of USG were in favor of malignant PNST (MPNST). Finally, the histopathology and immunohistochemistry features were found to be consistent with that of MPNST.

            Conclusion:

            This case is an example of the additive value of USG over MRI in identification of MPNSTs that can be helpful for appropriate management.

            Main article text

            Background

            Among the peripheral nerve sheath tumors (PNST), neurofibromas (NFs) are benign, usually single and commonly occur anywhere in the body, there is a low incidence of involvement of hands (0.8%) as a site of occurrence [1]. Malignant PNST (MPNST) affects 0.001% of the population [2] with a pre-dilection for extremities [3]. Magnetic resonance imaging (MRI) can sometimes differentiate between benign NF and MPNST. The current standard of management relies on MRI for surgical planning. Fluorodeoxyglucose positron-emission tomography (FDG-PET) is being increasingly deployed to help differentiate between benign NF and MPNST. Histopathology (HP) can also be non-specific unless complemented by immunohistochemistry (IHC) [4]. A number of ultrasonography (USG) features have been described that can potentially complement MRI in differentiating benign NF from MPNST [5,6]. We report a case having USG features of MPNST, which was pre-operatively identified as NF both by MRI and fine needle aspiration cytology (FNAC), and then, finally, proven to be MPNST with the help of HP and IHC.

            Case Presentation

            A 28-year-old male had an asymptomatic swelling in the right forearm for 12 years; this had progressively grown bigger to encroach the entire forearm. On examination, there was a 10-cm, hard, fixed, and non-tender lump with its major portion on the proximal radial aspect of the right forearm (Figure 1). MRI showed multiple well outlined, oval and solid masses of varying size in the intermuscular location, stretching the adjacent muscles without invasion. All lesions showed post-Gadolinium enhancement (Figure 2). Sonographically, there were multiple well outlined, oval and solid masses of varying size (78 × 36 mm, 51 × 40 mm, and 36 × 25 mm) and echotexture; situated in the anterior, posterior, and medial compartments of the right forearm adjacent to the flexor digitorumprofundus, lying in between the supinator and the brachioradialis muscles with the median nerve in its immediate vicinity (Figure 3). The duplex study of the lesion as well as radial and ulnar arteries revealed minimum intralesional vascular signal with no evidence of compression of distal arterial flow by the mass. Considering the size of the lesion and presence of the intra-lesional vascularity, the sonography team recommended FNAC correlation. FNAC from that mass revealed the feature of spindle cell mesenchymal lesion, consistent with neurofibroma. The MRI and FNAC features directed the provisional diagnosis to neurofibroma. Excision and biopsy were done.

            Figure 1.

            Preoperative appearance of the right forearm swelling.

            Figure 2.

            MRI: Multiple soft tissue masses showing post-contrast enhancement.

            Histopathologic features were compatible with that of Grade 1 MPNST with mitotic rate of 3/10 high power field belonging to pT2a (tumor size 7 × 5 cm), pNx, and pMx.On IHC, cells were negative for S100 which suggested likelihood for MPNST (Figure 4). In addition, cells were also negative for Desmin, smooth muscle actin, and HMB45.

            Follow-up on 18th post-operative day (Figure 5) showed no clinical sign of functional impairment, neurological deficit, or local recurrence. A regional ultrasound scan revealed no definite lesion, and the intermuscular spaces were hypoechoic due to post-excision residual inflammatory collection (Figure 6).

            Discussion

            The ultrasound features of the lesion, which were suggestive of MPNST, were the size of lesion being greater than 50 mm, irregular margin, hypoechogenicity with heterogeneous echotexture, and intra-lesional vascular signal. The vascular signal, which was probably from vasa nervorum is a feature in favor of malignancy, was considered of high clinical significant only retrospectively. Retrospective analysis of the ultrasound scan revealed additional features such as absence of intra-lesional cystic areas and presence of peri-lesional edema, which is considered significant [7]. Besides, the pre-operative MRI that stated about contrast enhancement was lacking detail in term of the enhancement pattern being peripheral or heterogeneous which in turn could have suggested the likelihood of the lesion being an MPNST. The reported imaging features are summarized in Table 1.

            Figure 3.

            USG: Multiple soft tissue masses.

            Figure 4.

            Immunocyto-histochemistry revealed malignant nerve sheath tumor.

            Figure 5.

            After operation.

            Figure 6.

            USG findings after operation.

            Extremities are among the sites reported for the commonest involvement by MPNST [8]. MPNST has been observed to arise either from proximal extremity involving a major nerve trunk [9] or from subcutaneous tissue of distal extremity without involving a major nerve trunk [10]. Most of the MPNSTs are more than 5 cm at the time of diagnosis [11].

            MPNST on MRI may appear as isointense to muscle or heterogeneous in T1 [6], but low signal in T2 due to its high collagen content [7]. Yu et al. [10] in their series did not find difference in T1 and T2 signals as a significant discriminator among benign PNSTs and MPNSTs. Large diameter (over 5 cm), ill-defined margin, intratumoral lobulation, peri-tumoral edema, and adjacent bone destruction are described as significantly discriminative imaging features of MPNST from benign [10,12]. Wasa et al. [7] in addition to dimension and peri-lesional edema described the presence of peripheral enhancing pattern and intra-tumoral cystic lesions as pathognomonic. The heterogeneous enhancement owing to hemorrhage or necrosis may also suggest likelihood of MPNSTs [13]. MPNST is often devoid of target sign, fascicular sign, split fat sign, and cystic changes [7,14]. Yu et al. [10] did not find the absence of target sign, split fat sign, and cystic change as a significant discriminator of MPNST from benign ones.

            Reported features of MPNST on high-resolution USG includes connection with a peripheral nerve, fusiform shape, inhomogeneity, and hypoehoicity with hyperchoic and irregularly thickened outer nerve sheath [9]. Findings that are described as suspicion raiser for MPNST include diameter larger than 5 cm, poorly defined outer margin [6], central necrosis or hemorrhage, edema, and calcification. Color and power and spectral Doppler surrogates of vascular changes evincing malignancy such as occlusion, stenosis, shunts, trifurcation, and loops [5] are recommended to be sought for. In addition, demonstration of hypertrophied vasa nervorum as “cork-screw type vessels,” increased vascularity [15], high velocity in newly formed vessels, variability of velocity and spectral waveform in different parts of the same tumor, and low resistance index in the presence of arterio-venous communication [6] are also suggestive of malignancy.Histological appearance of MPNST is considered non-specific which is monotonous spindle cells arranged in intersecting fascicles. Though there is no pathognomonic molecular or immunohistochemical study for MPNST, S100 protein is positive in 50%–70% of cases and low in high-grade MPNSTs, while a strong and diffuse staining excludes the diagnosis of MPNST in most instances. Identification of ultrastructural features of Schwann cells by electron microscopy has also been suggested as the most reliable method of diagnosis [4].

            Table 1.
            Comparative features of benign and MPNST on multi-modality imaging.
            IMAGING FEATURESMODALITYMPNSTNEUROFIBROMASCHWANNOMA
            ShapePlain X-ray, ultrasound, MRI, CTFusiformVariableVariable
            SizePlain X-ray, ultrasound, MRI, CTDiameter > 5 cmSmallerSmall
            Margin definitionUltrasound, MRI, CTIll definedWell definedWell defined
            CalcificationUltrasound, MRI, CTPresentPresent in long standing cases
            Central necrosis/hemorrhageUltrasound, MRI, CTPresentPresent in long standing cases
            CT appearanceCTHeterogeneous ± high attenuation values in unenhanced CTHypodense + minimal or no enhancementLow-to-intermediate attenuation + intense enhancement
            Ultrasound appearanceUltrasoundHypoechoic, heterogeneoushypoechoic+ homogeneous with posterior acoustic enhancement
            Neural distributionUltrasound, MRIAlong major nerve trunkLocated along cutaneous or deep nerves
            Position of parent nerveUltrasound, MRIOften lies central to lesionCentralUsually eccentric
            Intra-tumor cystsUltrasound, MRIOccasionalRareCommon
            Bony destructionUltrasound, MRIPresentAbsentAbsent
            Peri-lesional edemaUltrasound, MRIPresentAbsentAbsent
            Corkscrew-vessels, loops, shunt, trifurcationDoppler ultrasound, angiographyOftenSometimesSometimes
            High PSV ± low RISpectral DopplerPresentAbsentAbsent
            Target signMRIAbsentPresent, oftenPresent
            Fascicular signMRIOccasionalPresentPresent
            Split fat signMRIAbsentPresentPresent
            T1 enhancementMRIOften heterogeneousOften homogeneous
            Thin T2 hyperintense rimMRIAbsentRarePresent
            Post contrast enhancementMRISolid, peripheral, and heterogeneousCentralPeripheral and heterogeneous
            18-FDG avidityPET/CTHigh SUVsLow SUVsLow-to-intermediate SUVs
            MDP uptakeBone scintigraphyMild uptakeVariableVariable
            Ga-67 uptakeGa-67 scintigraphyHigh uptakeLow uptakeLow uptake

            CT = computed tomography; MDP = methylene diphosphonate; PSV = peak systolic velocity; RI = resistive index; SUV = standardized uptake value.

            Our limitations were that we could not perform nuclear imaging and we could not determine the association of this case with neurofibromatosis type 1.

            Conclusions

            Careful identification of USG and MRI features can complement each other in the categorization of PNST in terms of benign or malignant and thus the two imaging modalities in combination can guide institution of appropriate management.

            Acknowledgement

            The authors would like to thank the medical staff taking care of

            the patient.

            List of abbreviations

            CT

            Computed tomography

            FNAC

            Fine needle aspiration cytology

            HP

            Histopathology

            IHC

            Immunohistochemistry

            MPNST

            Malignant Peripheral Nerve Sheath Tumor

            MRI

            Magnetic Resonance Imaging

            NF

            Neurofibroma

            PET

            Positron emission tomography

            PNST

            Peripheral nerve sheath tumor

            USG

            Ultrasonography

            Consent for publication

            Informed consent was obtained from the patient.

            Ethical approval

            IEC approval was obtained.

            References

            1. Basheer H, Rabia F, Basheer H, el-Helw K.. Neurofibromas of digital nerves. J Hand Surg. 1997. Vol. 22(1):61–3

            2. Hruban RH, Shiu MH, Senie RT, Woodruff JM. Malignant peripheral nerve sheath tumors of the buttock and lower extremity. A study of 43 cases. Cancer. 1990. Vol. 66(6):1253–65

            3. Wu CC, Peng HL, Su CT, Lu TN, Lee CC, Chen LK. Mesenteric and retroperitoneal malignant peripheral nerve sheath tumors in a patient with neurofibromatosis type 1. Chin J Radiol. 2003. Vol. 28:193–8

            4. Farid M, Demicco EG, Garcia R, Ahn L, Merola PR, Cioffi A, et al.. Malignant peripheral nerve sheath tumors. Oncologist. 2014. Vol. 19(2):193–201

            5. Chatzistefanou A, Mantatzis M, Deftereos S, Mintzopoulou P, Prassopoulos P.. Peripheral nerve sheath tumors. Benign or malignant? The role of MRI and ultrasonography in a case report. J Neuroimaging. 2014. Vol. 24(3):308–10

            6. Gruber H, Glodny B, Bendix N, Tzankov A, Peer S.. Highresolution ultrasound of peripheral neurogenic tumors. Eur Radiol. 2007. Vol. 17(11):2880–8

            7. Wasa J, Nishida Y, Tsukushi S, Shido Y, Sugiura H, Nakashima H, et al.. MRI features in the differentiation of malignant peripheral nerve sheath tumors and neurofibromas. AJR Am J Roentgenol. 2010. Vol. 194(6):1568–74

            8. Pilavaki M, Chourmouzi D, Kiziridou A, Skordalaki A, Zarampoukas T, Drevelengas A.. Imaging of peripheral nerve sheath tumors with pathologic correlation: pictorial review. Eur J Radiol. 2004. Vol. 52:229–39

            9. Rafailidis V, Kaziani T, Theocharides C, Papanikolaou A, Rafailidis D.. Imaging of the malignant peripheral nerve sheath tumour with emphasis on ultrasonography: correlation with MRI. J Ultrasound. 2014. Vol. 17(3):219–2310

            10. Yu Y, Wu J, Ye J, Chen M.. Radiological findings of malignant peripheral nerve sheath tumor: reports of six cases and review of literature. World J Surg Oncol. 2016. Vol. 14:142

            11. Ducatman BS, Scheithauer BW, Piepgras DG, Reiman HM, Ilstrup DM. Malignant peripheral nerve sheath tumors. A clinicopathologic study of 120 cases. Cancer. 1986. Vol. 57:2006–21

            12. Kakkar C, Shetty CM, Koteshwara P, Bajpai S.. Telltale signs of peripheral neurogenic tumors on magnetic resonance imaging. Indian J Radiol Imaging. 2015. Vol. 25(4):453–8.

            13. Gupta G, Maniker A.. Malignant peripheral nerve sheath tumors. Neurosurg Focus. 2007. Vol. 22(6):E12

            14. Chee DW, Peh Wc, Shek TW. Pictorial essay: imaging of peripheral nerve sheath tumors. Can Assoc Radiol J. 2011. Vol. 62:176–82

            15. Murphy MD, Smith WS, Smith SE, Kransdorf MJ, Temple HT. From the archives of the AFIP. Imaging of musculoskeletal neurogenic tumors: radiologic-pathologic correlation. Radiographics. 1999. Vol. 19:1253–80.

            Summary of the case

            Patient (gender, age) 1Male, 28 years old
            Final diagnosis 2Malignant peripheral nerve sheath tumor of right forearm
            Symptoms 3Asymptomatic swelling
            Medications 4N/A
            Clinical procedure 5MRI, Ultrasound & Duplex, FNAC, Excision & Biopsy, HP and IHC
            Specialty 6Radiology and imaging

            Author and article information

            Journal
            European Journal of Medical Case Reports
            EJMCR
            Discover STM Publishing Ltd.
            2520-4998
            30 May 2018
            : 2
            : 2
            : 75-79
            Affiliations
            [1. ]National Institute of Nuclear Medicine and Allied Sciences (NINMAS), BAEC, Dhaka, Bangladesh
            [2. ]National Institute of Nuclear Medicine and Allied Sciences (NINMAS), Dhaka, Bangladesh
            [3. ]National Institute of Traumatology, Orthopedic and Rehabilitation, Dhaka, Bangladesh
            Author notes
            [* ] Corresponding Author: Nasreen Sultana National Institute of Nuclear Medicine and Allied Sciences (NINMAS), BAEC, Dhaka, Bangladesh. nasreeninm@ 123456yahoo.com
            Article
            ejmcr-2-75
            10.24911/ejmcr/2/17
            2b16c086-cb04-4499-9965-87346701398d
            © Nasreen Sultana, Azmal kabir Sarker, Sajedur Reza Faruquee, Mizanur Rahman, Jasmine Ara Haque

            This is an open access article distributed in accordance with the Creative Commons Attribution (CC BY 4.0) license: https://creativecommons.org/licenses/by/4.0/) which permits any use, Share — copy and redistribute the material in any medium or format, Adapt — remix, transform, and build upon the material for any purpose, as long as the authors and the original source are properly cited.

            History
            : 11 March 2018
            : 27 April 2018
            Categories
            CASE REPORT

            MRI,USG,malignant peripheral nerve sheath tumor

            Comments

            Comment on this article